Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Three series of Aurora kinase inhibitors prepared and tested at AstraZeneca

Aug. 31, 2004

ViRexx seeks Canadian clearance for phase I study of Occlusin

Aug. 31, 2004

SBIR grant funds VEGI development at ProteomTech

Aug. 31, 2004

New data submitted in support of clofarabine NDA

Aug. 31, 2004

Phase II results on the activity of BMS-247550 monotherapy in advanced colorectal cancer

Aug. 31, 2004

Roche seeks European approval of Tarceva for NSCLC

Aug. 30, 2004

IND filing for Provecta

Aug. 30, 2004

New caspase activators prepared and tested by Cytovia researchers

Aug. 30, 2004

Antiangiogenic agents targeting VEGFR kinase designed at Novartis

Aug. 30, 2004

Sterix presents new dual aromatase/steroid sulfatase inhibitor

Aug. 26, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...